Björn Guðbjörnsson

The timing of glucocorticoid administration in rheumatoid arthritis

Nils Gunnar Arvidson, Björn Guðbjörnsson, Anders Larsson et al. · Annals of the Rheumatic Diseases · 1997 · 161 citations · Full text

Medicine, Internal Medicine, Pharmacology +15

The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries

Pil Højgaard, Bente Glintborg, Lars Erik Kristensen et al. · Lara D. Veeken · 2016 · 141 citations · Full text

Public Health, Biostatistics, Pharmacotherapy +13

Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor Antagonists

Einar S. Björnsson, Baldvin I. Gunnarsson, Gerður Gröndal et al. · Clinical Gastroenterology and Hepatology · 2014 · 130 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin et al. · BMJ · 2020 · 113 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Johan Askling et al. · Annals of the Rheumatic Diseases · 2019 · 90 citations

Medicine, Clinical Sciences, Pharmacotherapy +14